Munich-based industrial holding ADCURAM has sold its subsidiary Nuvisan Pharma Holding GmbH effective 12 December 2014. The new owners are a highly regarded Southern German family office and the management team led by Dr. Dietrich Bruchmann. ADCURAM has thus now also sold the early-phase business, having successfully divested the late-phase branch to Japanese investor Linical in November 2014. Continue reading
Tag Archives: Nuvisan Pharma Holding GmbH
ADCURAM sells Nuvisan’s Clinical Drug Development Business to Japanese Strategic Investor Linical
Munich-based industrial holding ADCURAM Group AG and its Nuvisan Pharma Holding GmbH subsidiary have divested their Clinical Drug Development activities to Linical Co. Ltd. a leading Japanese clinical research organization (CRO). The complex carve out transaction was settled with economic effect as of 30 November 2014. Continue reading